In silico modeling of aspalathin and nothofagin against SGLT2

Journal of Theoretical and Computational Chemistry

Volumn 14, Issue 8, 2015, Pages

  Liu, Wei ^a   Wang, Huanjie ^a   Meng, Fancui ^a  

^a TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

aspalathin; homology modeling; molecular docking; molecular dynamics; nothofagin; SGLT2 inhibitor

Indexed keywords

EID: 84955187389     PISSN: 02196336     EISSN: None     Source Type: Journal    
DOI: 10.1142/S021963361550056X     Document Type: Article

References (25)

1. Dwarakanathan A, Diabetes update, J Insur Med 38(1):20-30, 2006.
2. Isaji M, Sodium-glucose cotransporter inhibitors for diabetes, Curr Opin Investig Drugs 8 (4):285-292, 2007.
3. Kinne RK, Castaneda F, SGLT inhibitors as new therapeutic tools in the treatment of diabetes, Handb Exp Pharmacol 203:105-126, 2011.
4. Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH, Recent discovery of plantderived anti-diabetic natural products, Nat Prod Rep 29:580-606, 2012.
5. de Beer D, Malherb CJ, Beelders T, Willenburg EL, Brand DJ, Joubert E, Isolation of aspalathin and nothofagin from rooibos (Aspalathus linearis) using high-performance countercurrent chromatography: Sample loading and compound stability considerations, J Chromatogr A 1381:29-36, 2015.
6. Snijman PW, Joubert E, Ferreira D, Li XC, Ding YQ, Gree IR, Gelderblom WCA, Antioxidant activity of the dihydrochalocones aspalathin and nothofagin and their corresponding °avones in relation to other rooibos (Aspalathus linearis) °avonoids, epigallocatechin gallate, and trolox, J Agric Food Chem 57(15):6678-6684, 2009.
7. Snijman PW, Swanevelder S, Joubert E, Green IR, Gelderblom WCA, The antimutagenic activity of the major °avonoids of rooibos (Aspalathus linearis): Some doseresponse e® ects on mutagen activation-°avonoid interactions, Mutat Res 631:111-123, 2007.
8. Lee W, Bae JS, Anti-in°ammatory e® ects of aspalathin and nothofagin from rooibos (aspalathus linearis) in vitro and in vivo, In°ammation 38(4):1502-1516, 2015.
9. Muller CJ, Joubert E, de Beer D, Sanderson M, Malherbe CJ, Fey SJ, Louw J, Acute assessment of an aspalathin-enriched green rooibos (Aspalathus linearis) extract with hypoglycemic potential, Phytomedicine 20(1):32-39, 2012.
10. Son MJ, Minakawa M, Miura Y, Yagasaki K, Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice, Eur J Nutr 52(6):1607-1619, 2013.
11. White JR, Apple trees to sodium glucose co-transporter inhibitors: A review of SGLT2 inhibition, Clin Diabetes 28:5-10, 2010.
12. Faham S, Watanabe A, Besserer GM, Cascio D, Specht A, Hirayama BA, Wright EM, Abramson J, The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na\+/sugar symport, Science 321:810-814, 2008.
13. Prime, version 2.1, Schrodinger, LLC, New York, NY, 2009.
14. MacroModel, version 9.7, Schrodinger, LLC, New York, NY, 2009.
15. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS, Glide: A new approach for rapid, accurate docking and scoring, J Med Chem 47(7):1739-1749, 2004.
16. Wolf MG, Hoeing M, Aponte-Santamariá C, Grubmuller H, Groenhof G, g membed: E±cient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation, J Comp Chem 31:2169-2174, 2010.
17. Lomize MA, Lomize AL, Pogozheva ID, Mosberg HI, OPM: Orientations of proteins in membranes database, Bioinformatics 22:623-625, 2006.
18. Hess B, Kutzner C, van der Spoel D, Lindahl E, GROMACS 4: Algorithms for highly e±cient, load-balanced, and scalable molecular simulation, J Chem Theory Comput 4:435-447, 2008.
19. Jambeck JP, Lyubartsev AP, Derivation and systematic validation of a re¯ned all-atom force ¯eld for phosphatidylcholine lipids, J Phys Chem B 116:3164-3179, 2012.
20. Kumari R, Kumar R, Consortium OSDD, Lynn A, g mmpbsa-a gromacs tool for highthroughput MM-PBSA calculations, J Chem Inf Model 54(7):1951-1962, 2014.
21. Nakka S, Guruprasad L, Structural insights into the active site of human sodium dependent glucose co-transporter 2: Homology modeling, molecular docking, and 3D-QSAR studies, Aust J Chem 65(9):1314-1324, 2012.
22. Wang QQ, Ning LL, Niu YZ, Liu HX, Yao XJ, Molecular mechanism of the inhibition and remodeling of human islet amyloid polypeptide(hIAPP1-37) oligomer by resveratrol from molecular dynamics simulation, J Phys Chem B 119(1):15-24, 2015.
23. Leonis G, Avramopoulos A, Salmas RE, Durdagi S, Yurtsever M, Papadopoulos MG, Elucidation of conformation states, dynamics, and mechanism of binding in human-opioid receptor complexes, J Chem Inf Model 54(8):2294-2308, 2014.
24. Anwar MA, Panneerselvam S, Shah M, Choi S, Insights into the species-speci¯c TLT4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection, Sci Rep 5:7657, 2015.
25. QikProp, version3.2, Schrodinger, LLC, New York, NY, 2009.